Aspire Biopharma Holdings, Inc. Share Price
ASBPAspire Biopharma Holdings, Inc. Stock Performance
Open $0.09 | Prev. Close $0.10 | Circuit Range N/A |
Day Range $0.09 - $0.09 | Year Range $0.08 - $11.92 | Volume 18,910 |
Average Traded $0.09 |
Aspire Biopharma Holdings, Inc. Share Price Chart
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Aspire Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
23-Dec-25 | $0.09 | $0.10 | +0.00% |
22-Dec-25 | $0.10 | $0.10 | -3.06% |
19-Dec-25 | $0.10 | $0.10 | -1.01% |
18-Dec-25 | $0.09 | $0.10 | +4.21% |
17-Dec-25 | $0.10 | $0.10 | -5.94% |
16-Dec-25 | $0.10 | $0.10 | -5.61% |
15-Dec-25 | $0.11 | $0.11 | +10.31% |